Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-15-049023
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-30 18:47:49
Reporting Period:
2015-06-30
Filing Date:
2015-06-30
Accepted Time:
2015-06-30 18:47:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1454789 Catabasis Pharmaceuticals Inc CATB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291804 Jean George C/o Advanced Technology Ventures
500 Boylston Street Suite 1380
Boston MA 02108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-30 674,446 $0.00 674,446 No 4 C Indirect See Footnote
Common Stock Acquisiton 2015-06-30 304,309 $0.00 978,755 No 4 C Indirect See Footnote
Common Stock Acquisiton 2015-06-30 574,979 $0.00 574,979 No 4 C Indirect See Footnote
Common Stock Acquisiton 2015-06-30 78,342 $0.00 78,342 No 4 C Indirect See Footnote
Common Stock Acquisiton 2015-06-30 155,188 $12.00 1,133,943 No 4 P Indirect See Footnote
Common Stock Acquisiton 2015-06-30 91,166 $12.00 666,145 No 4 P Indirect See Footnote
Common Stock Acquisiton 2015-06-30 12,422 $12.00 90,764 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2015-06-30 8,666,667 $0.00 674,446 $0.00
Common Stock Series B Preferred Stock Disposition 2015-06-30 3,910,392 $0.00 304,309 $0.00
Common Stock Series B Preferred Stock Disposition 2015-06-30 7,388,491 $0.00 574,979 $0.00
Common Stock Series B Preferred Stock Disposition 2015-06-30 1,006,712 $0.00 78,342 $0.00
Common Stock Stock Option (right to buy) Acquisiton 2015-06-30 11,094 $0.00 11,094 $12.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
11,094 2025-06-29 No 4 A Direct
Footnotes
  1. The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  2. These shares are held directly by Advanced Technology Ventures VIII, L.P. ("ATV VIII"). ATV Associates VIII, LLC ("ATV A VIII") is the General Partner of ATV VIII and exercises voting and dispositive authority over the shares held by ATV VIII. Voting and dispositive decisions of ATV A VIII are made collectively by Michael A. Carusi, Ms. George, Steven N. Baloff, Robert C. Hower and William C. Wiberg (collectively, the "ATV VIII Managing Directors"). Ms. George disclaims beneficial ownership of the shares held by ATV VIII except to the extent of their pecuniary interest therein.
  3. These shares are owned directly by Lightstone Ventures, L.P. ("LSV"). LSV Associates, LLC ("LSV GP") is the General Partner of Lightstone Ventures, L.P. and exercises voting and dispositive authority over the shares held by LSV. Voting and dispositive decisions of LSV GP are made collectively by Michael A. Carusi, Jean George, Ralph E. Christoffersen and Henry A. Plain, Jr. Ms. George disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  4. These shares are owned directly by Lightstone Ventures (A), L.P. ("LSV(A)"). LSV GP is the General Partner of LSV(A) and exercises voting and dispositive authority over the shares held by LSV(A). Voting and dispositive decisions of LSV GP are made collectively by Michael A. Carusi, Jean George, Ralph E. Christoffersen and Henry A. Plain, Jr. Ms. George disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  5. This option was granted on June 30, 2015 and vests over three years, with one-third of the shares vesting on each anniversary of the grant date until the third anniversary of the grant date.